Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...
Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason ...
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
The FTC accuses major PBMs of inflating insulin prices ... PBMs have long been seen as the “middlemen” getting in the way of lower drug prices, with negotiations often resulting in cheaper ...
In recent years, many patients like Mitchell have faced soaring insulin costs. These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers and ...
One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...
No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...
The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback